Differential regulation of prostaglandin e biosynthesis by interferon-γ in colonic epithelial cells

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1091-1097

  Wright, Karen L ^a   Weaver, Sean A ^a   Patel, Kajal ^a   Coopman, Karen ^a   Feeney, Mark ^b   Kolios, George ^c   Robertson, Duncan A F ^b   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Colon; Cyclooxygenase; Cytokine; Inflammation; Prostaglandin; Synthase

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; MESSENGER RNA; PROSTAGLANDIN E; PROSTAGLANDIN E2;

ARTICLE; BIOSYNTHESIS; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EVALUATION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM; STIMULATION; UPREGULATION;

ANIMALS; CACO-2 CELLS; COLON; CYCLOOXYGENASE INHIBITORS; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; EVALUATION STUDIES; HT29 CELLS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICROSOMES; PROSTAGLANDINS E; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 2342584701     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705719     Document Type: Article

References (40)

1. ARIAS-NEGRETE, S., KELLER, K. & CHADEE, K. (1995). Pro-inflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun., 208, 582-589.
2. 2 production by IFN-γ in human macrophages. J. Immunol., 161, 2441-2448.
3. BREESE, E.J., MICHIE, C.A., NICHOLLS, S.W., MURCH, S.H., WILLIAMS, C.B., DOMIZIO, P., WALKERSMITH, J.A. & MACDONALD, T.T. (1994). Tumor necrosis factor-α producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology, 106, 1455-1466.
4. DANNENBERG, A.J. & ZAKIM, D. (1999). Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin. Oncol., 26, 499-504.
5. DEBINSKI, H., FORBES, A. & KAMM, M.A. (1997). Low dose interferon-γ for refractory Crohn's disease. Italian J. Gastroenterol., 29, 403-406.
6. DIXON, D.A., KAPLAN, C.D., MCINTYRE, T.M., ZIMMERMAN, G.A. & PRESCOTT, S.M. (2000). Post-transcriptional control of cyclooxygenase-2 gene expression. J. Biol. Chem., 275, 11750-11757.
7. DUBOIS, R.N., ABRAMSON, S.B., CROFFORD, L., GUPTA, R.A., SIMON, L.S., VAN DE PUTTE, L.B.A. & LIPSKY, P.E. (1998). Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
8. EVANS, G.S., FLINT, N. & POTTEN, C.S. (1994). Primary cultures for studies of cell regulation and physiology in intestinal epithelium. Annu. Rev. Physiol., 56, 399-417.
9. FU, J.Y., MASFERRER, J.L., SEIBERT, K., RAZ, A. & NEEDLEMAN, P. (1991). The induction and suppression of prostaglandin H2 synthase (cylooxygenase) in human monocytes. J. Biol. Chem., 265, 16737-16740.
10. GILROY, D.W., COLVILLE-NASH, P.R., WILLIS, D., CHIVERS, J., PAUL-CLARK, M.J. & WILLOUGHBY, D.A. (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med., 5, 698-701.
11. 2 synthase expression. J. Biol. Chem., 277, 16355-16364.
12. HEMLER, M., LANDS, W.E.M. & SMITH, W.L. (1976). Purification of the cyclo-oxygenase that forms prostaglandins. Demonstration of the two forms of iron in the holoenzyme. J. Biol. Chem., 251, 5575-5579.
13. HERSCHMAN, H.R. (1996). Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299, 125-140.
14. HUANG, Z.F., MASSEY, J.B. & VIA, D.P. (2000). Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) in human in vitro differentiated macrophages. Biochem. Pharmacol., 59, 187-194.
15. JAKOBSSON, P.-J., THOREN, S., MORGENSTERN, R. & SAMUELSSON, B. (1999). Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U.S.A., 96, 7220-7225.
16. JOBIN, C., MORTEAU, O., HAN, D.S. & SARTOR, R.B. (1998). Specific NF-κB blockade selectively inhibits tumour necrosis factor-α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology, 95, 537-543.
17. KOLIOS, G., BROWN, Z., ROBSON, R.L., ROBERTSON, D.A.F. & WESTWICK, J. (1995). Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br. J. Pharmacol., 116, 2866-2872.
18. KOLIOS, G., WRIGHT, K.L., JORDAN, N.J., LEITHEAD, J.B., ROBERTSON, D.A.F. & WESTWICK, J. (1999). C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte- derived cytokines. Eur. J. Immunol., 29, 530-536.
19. KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W. & HERSCHMAN, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872.
20. MATSUURA, H., SAKAUE, M., SUBBARAMAIAH, K., KAMITANI, H., ELING, T.E., DANNENBERG, A.J., TANABE, T., INOUE, H., ARATA, J. & JETTEN, A.M. (1999). Regulation of cyclooxygenase-2 by interferon-γ and transforming growth factor-α in normal human epidermal keratinocytes and squamous carcinoma cells. J. Biol. Chem., 274, 19148-29138.
21. MCCARTNEY, S.A., MITCHELL, J.A., FAIRCLOUGH, P.D., FARTHING, M.J.G. & WARNER, T.D. (1999). Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment. Pharmacol. Ther., 13, 1115-1117.
22. MORTEAU, O., MORHAM, S.G., SELLON, R., DIELEMAN, L.A., LANGENBACH, R., SMITHIES, O. & SARTOR, R.B. (2000). Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest., 105, 469-478.
23. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem., 275, 32783-32792.
24. PANG, L. & KNOX, A.J. (1997). Effect of interleukin-1β, tumour necrosis factor-α and interferon-γ on the induction of cyclooxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol., 121, 579-587.
25. + T cells. Immunity, 1, 553-562.
26. REDDY, S.T., WADLEIGH, D.J. & HERSCHMAN, H.R. (2000). Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J. Biol. Chem., 275, 3107-3113.
27. REUTER, B.K., ASFAHA, S., BURET, A., SHARKEY, K.A. & WALLACE, J.L. (1996). Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest., 98, 2076-2085.
28. SHAO, J., SHENG, H., INOUE, H., MORROW, J.D. & DUBOIS, R.N. (2000). Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275, 33951-33956.
29. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276, 18075-18081.
30. SORIANI, M., LUSCHER, P. & TYRRELL, R.M. (1999). Direct and indirect modulation of ornithine decarboxylase and cyclooxygenase by UVB radiation in human skin cells. Carcinogenesis, 20, 727-732.
31. STICHTENOTH, D.O., THOREN, S., BIAN, H., PETERS-GOLDEN, M., JAKOBSSON, P.-J. & CROFFORD, L.J. (2001). Microsomal prostaglandin E synthase is regulated by pro-inflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J. Immunol., 167, 469-474.
32. TANIOKA, T., NAKATANI, Y., SEMMYO, N., MURAKAMI, M. & KUDO, I. (2000). Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem., 275, 32775-32782.
33. TARGAN, S.R., HANAUER, S.B., VAN DEVENTER, S.J., MAYER, L., PRESENT, D.H., BRAAKMAN, T., DEWOODY, K.L., SCHAIBLE, T.F. & RUTGEERTS, P.J. (1997). A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn's disease. Crohn's Disease cA 2 study Group. N. Engl. J. Med., 337, 1029-1035.
34. 4. Eur. J. Biochem., 267, 6428-6434.
35. VAN DEVENTER, S.J. (1997). Tumour necrosis factor and Crohn's disease. Gut, 40, 443-448.
36. WARHURST, A.C., HOPKINS, S.J. & WARHURST, G. (1998). Interferon-γ induces differential upregulation of α and β chemokine secretion in colonic epithelial cell lines. Gut, 42, 208-213.
37. WEAVER, S.A., RUSSO, M.P., WRIGHT, K.L., KOLIOS, G., JOBIN, C., ROBERTSON, D.A.F. & WARD, S.G. (2001). Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase-2 expression in colonic epithelial cells. Gastroenterology, 120, 1117-1127.
38. WRIGHT, K., WARD, S.G., KOLIOS, G. & WESTWICK, J. (1997). Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem., 272, 12626-12633.
39. WRIGHT, K.L., KOLIOS, G., WESTWICK, J. & WARD, S.G. (1999). Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. J. Biol. Chem., 274, 17193-17201.
40. YOSHIMATSU, K., GOLIJANIN, D., PATY, P.B., SOSLOW, R.A., JAKOBSSON, P.-J., DELELLIS, R.A., SUBBARAMAIAH, K. & DANNENBERG, A.J. (2001). Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res., 7, 3971-3976.